Concentra Group Holdings Parent, Inc. (CON)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $5.35B
Last updated: Nov 17, 2026 at 11:05 AM ET
Concentra Group Holdings Parent, Inc. (CON) P/E Ratio & Valuation Multiples
Concentra Group Holdings Parent (CON) trades at 25.3x trailing earnings and 2.4x sales. Its forward P/E is 22.0x. The median P/E across 12 similar companies is 22.1x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 15.0% higher over the next year. Its free cash flow yield is 4.7%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 25.3x |
| Forward P/E | 22.0x |
| Price to sales | 2.4x |
| Price to book | 10.8x |
| EV/EBITDA | 14.5x |
| Price to FCF | 21.4x |
|---|---|
| EV/FCF | 26.9x |
| PEG | N/A |
| FCF yield | 4.7% |
As of Nov 17, 2026
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CON
What is CON's forward P/E ratio?
Concentra Group Holdings Parent has a forward P/E ratio of 22.0x.
Is CON stock overvalued?
GNG's valuation label for CON is Fairly valued. Its P/E of 25.3x compares with a median of 22.1x across 12 similar companies.
What is CON's price to sales ratio?
Concentra Group Holdings Parent has a price to sales ratio of 2.4x.
CON pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors